Evolent Health Inc
NYSE:EVH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Malam Team Ltd
TASE:MLTM
|
IL |
|
Daiwa House Industry Co Ltd
OTC:DWAHY
|
JP |
|
N
|
Neways Electronics International NV
LSE:0NEB
|
NL |
|
Z
|
ZhongWang Fabric Co Ltd
SSE:605003
|
CN |
|
V
|
Vincit Oyj
OMXH:VINCIT
|
FI |
|
Airgain Inc
NASDAQ:AIRG
|
US |
|
C
|
CaoCao Inc
HKEX:2643
|
CN |
|
Rheinmetall AG
XETRA:RHM
|
DE |
|
RioCan Real Estate Investment Trust
TSX:REI.UN
|
CA |
|
E
|
Erin Energy Corp
OTC:ERINQ
|
US |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Evolent Health Inc
NYSE:EVH
|
317m USD |
Loading...
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
Loading...
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
27.5B USD |
Loading...
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
15.5B AUD |
Loading...
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY |
Loading...
|
|
| SE |
|
Sectra AB
STO:SECT B
|
50.2B SEK |
Loading...
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD |
Loading...
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
4.6B USD |
Loading...
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
261.2B INR |
Loading...
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.1B CNY |
Loading...
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Evolent Health Inc
Glance View
Evolent Health Inc. emerged in 2011 from a collaboration between The Advisory Board Company and the University of Pittsburgh Medical Center, with a mission to reshape healthcare delivery in the United States. As the healthcare landscape shifted towards value-based care models, where providers are compensated for keeping patients healthy rather than on the volume of services delivered, Evolent positioned itself as a pivotal partner for healthcare systems aiming to transition smoothly into this new paradigm. The company's core offerings revolve around its technology-driven platform, which integrates data analytics, care management, and clinical expertise to enable healthcare providers and payers to deliver more efficient and patient-centric care. By providing these services, Evolent helps its clients reduce costs and improve patient outcomes, thus thriving in a rapidly evolving industry. From a business perspective, Evolent Health generates revenue primarily through two streams: provider services and performance-based contracts. For its provider services, Evolent signs agreements with healthcare providers, offering them proprietary technology and consulting services, all designed to enhance their operational efficiency and clinical capabilities. The performance-based contracts, which are fundamental in a value-based care environment, allow Evolent to share in the financial benefits realized by its clients from improved patient care and cost savings. This model not only aligns Evolent's success with that of its clients but also positions the company at the heart of the healthcare value chain, asserting its influence through partnerships that are financially symbiotic.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Evolent Health Inc is 21.3%, which is above its 3-year median of 19.8%.
Over the last 3 years, Evolent Health Inc’s Gross Margin has decreased from 23.4% to 21.3%. During this period, it reached a low of 14.4% on Dec 31, 2024 and a high of 24.7% on Jun 30, 2023.